Nonrandom tissue distribution of mutant mtDNA

American Journal of Medical Genetics

Volumn 85, Issue 5, 1999, Pages 498-501

  Chinnery, Patrick F ^a,b   Zwijnenburg, Petra J G ^a   Walker, Mark ^a   Howell, Neil ^c   Taylor, Robert W ^a   Lightowlers, Robert N ^a   Bindoff, Laurence ^d   Turnbull, Douglass M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Heteroplasmy; MELAS; Mitochondrial disease; Mitochondrial DNA; Mitochondrial DNA segregation

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CHEEK MUCOSA; CLINICAL ARTICLE; DIABETES MELLITUS; EXTRACHROMOSOMAL INHERITANCE; FEMALE; HAIR FOLLICLE; HUMAN; MALE; MELAS SYNDROME; PERCEPTION DEAFNESS; POINT MUTATION; PRIORITY JOURNAL; RANDOMIZATION; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ADULT; BIOPSY, NEEDLE; DEAFNESS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; GENOMIC IMPRINTING; HAIR; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MUSCLE, SKELETAL; MUTATION; ORGAN SPECIFICITY; PEDIGREE; REPRODUCIBILITY OF RESULTS; VARIATION (GENETICS);

EID: 0033609846     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990827)85:5<498::AID-AJMG13>3.0.CO;2-8     Document Type: Article

References (31)

1. Attardi G, Yoneda M, Chomyn A. 1995. Complementation and segregation behavior of disease causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1271:241-248.
2. Campos Y, Bautista J, Gutierrez-Rivas E, Chinchon D, Cabello A, Segura D, Arenas J. 1995. Clinical heterogeneity in two families with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol Scand 91:62-65.
3. Chinnery PF, Turnbull DM. 1997a. Mitochondrial medicine. Q J Med 990: 657-666.
4. Chinnery PF, Turnbull DM. 1997b. The clinical features, investigation and management of patients with mitochondrial DNA defects. J Neurol Neurosurg Psychiatry 63:559-563.
5. Chinnery P, Howell N, Lightowlers R, Turnbull D. 1997. Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotype. Brain 120:1713-1721.
6. Chomyn A, Yoneda M, Daga A, Hurko O, Johns D, Lai ST, Nonaka I, Angelini C, Attardi G. 1992. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 89:4221-4225.
7. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Simonetti S, Angelini C, Donati MA, Garcia C, Martinuzzi A, Mosewich R, Servidei S, Zammarchi E, Bonilla E, DeVivo DC, Rowland LP, Schon EA, DiMauro S. 1992. MELAS: clinical features, biochemistry, and molecular genetics. Annals of Neurol 31:391-398.
8. Clayton DA. 1996. Mitochondrial DNA gets the drift. Nature Genet 14: 123-125.
9. DiMauro S. 1993. Mitochondrial encephalomyopathies. In: Rosenberg R, Prusiner S, DiMauro S, Barchi R, Kunkel L (eds) The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann, pp 665-694.
10. Dunbar DR, Moonie PA, Jacobs HT, Holt IJ. 1995. Different cellular backgrounds confer a marked advantage to either mutant or wild-type mitochondrial genomes. Proc Natl Acad Sci USA 92:6562-6566.
11. Ghosh SS, Fahy E, Bodis-Wollner I, Sherman J, Howell N. 1996. Longitudinal study of a heteroplasmic 3460 Leber hereditary optic neuropathy family by multiplexed primer-extension analysis and nucleotide sequencing. Am J Hum Genet 58:325-334.
12. Goto Y, Nonaka I, Horai S. 1990. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies [see comments]. Nature 348:651-653.
13. Hamazaki S, Koshiba M, Sugiyama T. 1993. Organ distribution of mutant mitochondrial tRNA(leu(UUR)) gene in a MELAS patient. Acta Pathol Japon 43:187-191.
14. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. 1995. The mitochondrial DNA transfer RNALeu-(UUR) A-→G(3243) mutation. A clinical and genetic study. Brain 118: 721-734.
15. Harding AE, Holt IJ, Sweeney MG, Brockington M, David MB. 1992. Prenatal diagnosis of mitochondrial DNA 8993 T-G disease. 50:629-633.
16. Huang C-C, Chen R-S, Chu N-S, Pang C-Y, Wei Y-H. 1996. Random mitotic segregation of mitochondrial DNA in MELAS syndrome. Acta Neurol Scand 93:198-202.
17. Jenuth JP, Peterson AC, Shoubridge EA. 1997. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nature Genet 16: 93-95.
18. Larsson N-G, Clayton DA. 1995. Molecular genetic aspects of human mitochondrial disorders. Ann Rev Genet 29:151-178.
19. Macmillan C, Lach B, Shoubridge EA. 1993. Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues in symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 43: 1586-1590.
20. Matthews PM, Hopkin J, Brown RM, Stephenson JB, Hilton-Jones D, Brown GK. 1994. Comparison of the relative levels of the 3243 (A-→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet 31:41-44.
21. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, Schon EA, Bonilla E, DiMauro S. 1993. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 3:43-50.
22. LeuUUR in patients with the MELAS phenotype. Hum Mol Genet 4:1689-1691.
23. Petruzzella V, Moraes CT, Sano MC, Bonilla E, DiMauro S, Schon EA. 1994. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 3:449-454.
24. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC. 1992. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379.
25. Santorelli FM, Shanske S, Jain KD, Tick D, Schon EA, DiMauro S. 1994. A T-→C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 44:972-974.
26. Shiraiwa N, Ishii A, Iwamoto H, Mizusawa H, Kagawa Y, Ohta S. 1993. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci 120:174-179.
27. Shoffner JM. 1996. Maternal inheritance and the evaluation of oxidative phosphorylation diseases. Lancet 348:1283-1288.
28. Schon EA, Bonilla E, DiMauro S. 1997. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 29:131-149.
29. Wallace DC. 1992. Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212.
30. Yoneda M, Chomyn A, Martinuzzi A, Hurko O, Attardi G. 1992. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci USA 89: 11164-11168.
31. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, Rowland LP. 1988. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38:1339-1346.